Completed PHASE2 INTERVENTIONAL 2-arm NCT01935804

Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes (Pioglitazone)

Phase 1 Study of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes

Sponsor: King Abdulaziz University

Conditions Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders

Updated 5 times since 2017 Last updated: Jun 16, 2014 Started: Jan 31, 2009 Primary completion: Jan 31, 2014 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Diabetes Mellitus and Diabetes Mellitus, Type 2 and is currently completed. King Abdulaziz University leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King Abdulaziz University

Data source: King Abdulaziz University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jeddah, Saudi Arabia